Expression of Tumor-rejection Antigens in Gynecologic Cancers
β Scribed by Tanaka, Shoko ;Tsuda, Naotake ;Kawano, Kouichirou ;Sakamoto, Masaru ;Nishida, Takashi ;Hashimoto, Takashi ;Shichijo, Shigeki ;Kamura, Toshiharu ;Itoh, Kyogo
- Book ID
- 108581858
- Publisher
- Wiley (Blackwell Publishing)
- Year
- 2000
- Tongue
- English
- Weight
- 103 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0910-5050
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The authors recently reported that the SART2 and SART3 antigens encode tumor epitopes recognized by HLAβA24βrestricted and tumorβspecific cytotoxic T lymphocytes (CTLs) established from esophageal carcinoma patients. The current study investigated these antigens to explor
We investigated in breast cancers the expression of the SART-1 gene encoding tumor rejection antigens. SART-1 mRNA was expressed in all of the samples tested. The SART-1 800 antigen was detectable in 20 of 50 (40%) breast cancer tissues and all breast cancer cell lines tested, but not in normal brea
We have reported a tumor-rejection antigen, SART1 259 , possessing tumor epitopes capable of inducing cytotoxic T lymphocytes (CTLs) in epithelial-cancer patients. This study investigated the expression of SART1 259 antigen in brain tumors, to explore for a potential molecule for use in specific imm